Inveresk To Add Allergy/Immunology Expertise Upon Merger With ClinTrials
Executive Summary
Inveresk Research will add allergy and immunology expertise to its contract research capabilities following its merger with Cary, N.C.-based ClinTrials.
You may also be interested in...
CROs Highlight Toxicology Revenue; Are Mergers Non-Toxic To Bottom Line?
Covance expects its expanding toxicology research to drive double-digit revenue growth through 2003
CROs Highlight Toxicology Revenue; Are Mergers Non-Toxic To Bottom Line?
Covance expects its expanding toxicology research to drive double-digit revenue growth through 2003
Corcept To Test Sluggish IPO Market For Biotechs
Corcept Therapeutics will test the sluggish market for biopharmaceutical initial public offerings with an IPO slated for June 10